✦ LIBER ✦

Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy

✍ Scribed by Williams, Mark E.; Bolton, W. Kline; Khalifah, Raja G.; Degenhardt, Thorsten P.; Schotzinger, Robert J.; McGill, Janet B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular outcomes in the Irbesarta

✍ T. Berl; L.G. Hunsicker; J.B. Lewis 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Diabetic nephropathy: renal structural s

✍ Michele Dalla Vestra; Paola Fioretto 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 74 KB

A Randomized Trial of Low-Protein Diet i

✍ Dussol, Bertrand; Iovanna, Cecilia; Raccah, Denis; Darmon, Patrice; Morange, Sop 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Maternal history of type 2 diabetes is a

✍ S. Hadjadj; F. Duengler; F. Torremocha; G. Faure-Gerard; F. Bridoux; M. Boissonn 📂 Article 📅 2007 🏛 Masson Editeur 🌐 French ⚖ 257 KB

Proteinuria reduction and progression to

✍ Robert C. Atkins; Esther M. Briganti; Julia B. Lewis; Lawrence G. Hunsicker; Gre 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Renoprotective effect of aliskiren monot

✍ Hamed, Amin T.; Taha, Mohammed M.; Nasser, Luay M. 📂 Article 📅 2013 🏛 Egypts Presidential Specialized Council for Educat 🌐 English ⚖ 563 KB